US Patent Issued to IMMIOS HOLDING, RIJKSUNIVERSITEIT GRONINGEN, ACADEMISCH ZIEKENHUIS GRONINGEN on Feb. 10 for "Anti-CD103 antibodies" (Dutch Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,733, issued on Feb. 10, was assigned to IMMIOS HOLDING B.V. (Oss, Netherlands), RIJKSUNIVERSITEIT GRONINGEN (Groningen, Netherlands) and ACADEMISCH ZIEKENHUIS GRONINGEN (Groningen, Netherlands).

"Anti-CD103 antibodies" was invented by Marco De Bruyn (Haren, Netherlands), Klaas Jan-Derek Kol (Groningen, Netherlands), Hans Wilhelm Nijman (Groningen, Netherlands), Hans Van Eenennaam (Velp, Netherlands) and Sander Martinus Johannes Van Duijnhoven (Uden, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-CD 103 antibodies, as well as use of these antibodies in diagnosis, prognosis, monitoring, and treatment o...